Corporate Greed
Economist Dean Baker: Systemic Change Needed to Fight Big Pharma Price Gouging
“We give companies patent monopolies that allow them to sell drugs at mark-ups of several thousand percent above their production costs. How can we be surprised when they lie or conceal information to push their drugs as widely as possible?”
